Consumer Retailing Healthcare Sector

Cytek Biosciences

Market Cap: US$328.0m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

Varex Imaging

Market Cap: US$327.1m

Designs, manufactures, and sells X-ray imaging components.

Nano-X Imaging

Market Cap: US$326.8m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.

TurnKey Capital

Market Cap: US$317.7m

HealthSpan Medical Systems, Inc. develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners.

Alpha Teknova

Market Cap: US$315.8m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Quantum-Si

Market Cap: US$313.8m

A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

National Research

Market Cap: US$313.8m

Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.

Outset Medical

Market Cap: US$312.1m

A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

Pacific Biosciences of California

Market Cap: US$312.1m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

EBR Systems

Market Cap: AU$476.3m

Develops implantable systems for wireless tissue stimulation.

XOMA Royalty

Market Cap: US$305.2m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

Aurora Cannabis

Market Cap: CA$418.2m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Imricor Medical Systems

Market Cap: AU$471.0m

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.

Rapport Therapeutics

Market Cap: US$301.8m

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

Cresco Labs

Market Cap: CA$413.1m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Phathom Pharmaceuticals

Market Cap: US$300.2m

A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.

Abeona Therapeutics

Market Cap: US$299.0m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Cryoport

Market Cap: US$298.3m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

Compass Therapeutics

Market Cap: US$293.2m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

Candel Therapeutics

Market Cap: US$293.1m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

Corvus Pharmaceuticals

Market Cap: US$293.0m

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

Heron Therapeutics

Market Cap: US$291.4m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

Oncology Institute

Market Cap: US$286.4m

An oncology company, provides various medical oncology services in the United States.

Cidara Therapeutics

Market Cap: US$285.6m

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

Rocket Pharmaceuticals

Market Cap: US$282.3m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Silence Therapeutics

Market Cap: US$280.5m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Tvardi Therapeutics

Market Cap: US$279.5m

Operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases.

Astria Therapeutics

Market Cap: US$279.3m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

Entrada Therapeutics

Market Cap: US$278.5m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

ADC Therapeutics

Market Cap: US$274.7m

Provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

Palvella Therapeutics

Market Cap: US$274.0m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.

Canopy Growth

Market Cap: CA$373.3m

Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.

Oceania Healthcare

Market Cap: NZ$456.3m

Owns and operates retirement villages and care centres in New Zealand.

Terns Pharmaceuticals

Market Cap: US$270.7m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Tonix Pharmaceuticals Holding

Market Cap: US$270.4m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

Aquestive Therapeutics

Market Cap: US$269.2m

Operates as a pharmaceutical company in the United States and internationally.